← Study Library
Animal · 2014
Preclinicalcounts toward this tierA dose-response study of thymosin β4 for the treatment of acute stroke
Morris DC, Cui Y, Cheung WL, Lu M, Zhang L, Zhang ZG, Chopp M · Journal of the Neurological Sciences
Preclinicalcounts toward this tier
Neurological recovery improved significantly at 2 and 12 mg/kg out to day 56, while 18 mg/kg did not differ from control; the modelled optimum was 3.75 mg/kg. The dose-response is an inverted U — the highest dose tested worked worst.
- Population
- Male Wistar rats after embolic middle cerebral artery occlusion, 10 per group
- Intervention
- Tβ4 2, 12 or 18 mg/kg intraperitoneally starting 24 h after stroke, then every three days for four more doses
- Comparator
- Vehicle
- Limitations
- Rat embolic stroke model, 10 animals per arm; no human stroke trial has followed. Directly relevant to dosing only as evidence that more is not reliably better.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental